DIANNA PITRE: Open Payments
NPI 1134751126 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,659 in 130 payments from 15 companies in 2025. Trend: 2023 $1,431 · 2024 $1,457 · 2025 $2,659
Food & beverage: $2,642Education: $17
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 31 | $548 |
| AstraZeneca Pharmaceuticals LP | 22 | $539 |
| GENZYME CORPORATION | 10 | $288 |
| Insmed, Inc. | 13 | $204 |
| Verona Pharma, Inc. | 9 | $199 |
| Viatris Specialty LLC | 8 | $166 |
| Actelion Pharmaceuticals US, Inc. | 10 | $161 |
| Grifols USA, LLC | 9 | $157 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $149 |
| Regeneron Healthcare Solutions, Inc. | 4 | $118 |
Products named: DUPIXENT, NUCALA, AIRSUPRA, Ohtuvayre, Arikayce, TRELEGY ELLIPTA, YUPELRI, OPSUMIT.
Industry payments across LA — which companies pay providers there.
